MicroRNA-205-5p: A Potential Therapeutic Target for Combating Unstable Atherogenesis?

Meng X, Yin J, Yu X, et al. MicroRNA-205-5p promotes unstable atherosclerotic plaque formation in vivo. Cardiovasc Drugs Ther. 2020;34(1):25–39.

Article  CAS  PubMed  Google Scholar 

Huang P, Zhang Y, Wang F, et al. MiRNA-205-5p regulates the ERBB4/AKT signaling pathway to inhibit the proliferation and migration of HAVSMCs induced by ox-LDL. Pathol Res Pract. 2022;233:153858.

Article  CAS  PubMed  Google Scholar 

Xiao Z, Xie Y, Huang F, et al. MicroRNA-205-5p plays a suppressive role in the high-fat diet-induced atrial fibrosis through regulation of the EHMT2/IGFBP3 axis. Genes Nutr. 2022;17(1):11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qian Q, Ma Q, Wang B, et al. MicroRNA-205-5p targets E2F1 to promote autophagy and inhibit pulmonary fibrosis in silicosis through impairing SKP2-mediated Beclin1 ubiquitination. J Cell Mol Med. 2021;25(19):9214–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang J, Wang X, Wen G, et al. miRNA-205-5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells. Oncol Rep. 2019;42(5):1677–88.

CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif